Product class:
|
Authorized package
|
Medicinal product class:
|
For human use
|
Package code:
|
1415911
|
Name of medicinal product:
|
ORALAIR 300 IR
|
Active substances:
|
|
ATC code:
|
V01AA02
|
Dosage form:
|
sublingual tablet
|
Route of administration:
|
oromucosal use
|
Strengh:
|
300IR
|
Amount in package:
|
30TK
|
Legal status for supply*:
|
Subject to medicinal prescription
|
Class of active substance:
|
|
Additional information:
|
|
Indication:
|
Treatment of grass pollen allergic rhinitis with or without conjunctivitis in adults, adolescents and children (above the age of 5) with clinically relevant symptoms, confirmed by a positive cutaneous test and/or a positive titre of the specific IgE to one of the grass pollen from the Pooideae grass homologous group1.
1 Pooideae (temperate) grass homologous group: Phleum pratense (Timothy grass), Anthoxanthum odoratum (Sweet vernal grass), Avena sativa (Oat), Dactylis glomerata (Orchard grass/Cocksfoot), Festuca spp. (Meadow fescue), Holcus lanatus (Velvet grass/Yorkshire fog), Hordeum vulgare (Barley), Lolium perenne (Perennial ryegrass), Poa pratensis (Kentucky bluegrass), Secale cereale (Cultivated rye), Triticum aestivum (Cultivated wheat).
|
Safety features:
|
No
|
Summary of product characteristics (SPC):
|
(last updated October 12, 2023)
|
Package information leaflet (PIL):
|
EST (last updated October 20, 2023)
|
Labelling:
|
(last updated October 20, 2023)
|
Last imported to Estonia:
|
Never imported to Estonia
|
Marketing authorization holder:
|
Stallergenes
|
Marketing authorization number:
|
672910
|
Marketing authorization issued on:
|
February 3, 2010
|
Marketing authorization expires on:
|
Unlimited
|
Marketing authorization procedure type:
|
Mutual recognition
|
Reference price:
|
|
Under reference price:
|
|
Reference price of daily dose:
|
|
Entry/Changing date:
October 20, 2023
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription
You can download Acrobat Reader fromhere